Literature DB >> 7775460

Site-directed mutagenesis identifies residues involved in ligand recognition in the human A2a adenosine receptor.

J Kim1, J Wess, A M van Rhee, T Schöneberg, K A Jacobson.   

Abstract

The A2a adenosine receptor is a member of the G-protein coupled receptor family, and its activation stimulates cyclic AMP production. To determine the residues which are involved in ligand binding, several residues in transmembrane domains 5-7 were individually replaced with alanine and other amino acids. The binding properties of the resultant mutant receptors were determined in transfected COS-7 cells. To study the expression levels in COS-7 cells, mutant receptors were tagged at their amino terminus with a hemagglutinin epitope, which allowed their immunological detection in the plasma membrane by the monoclonal antibody 12CA5. The functional properties of mutant receptors were determined by measuring stimulation of adenylate cyclase. Specific binding of [3H]CGS 21680 (15 nM) and [3H]XAC (4 nM), an A2a agonist and antagonist, respectively, was absent in the following Ala mutants: F182A, H250A, N253A, I274A, H278A, and S281A, although they were well expressed in the plasma membrane. The hydroxy group of Ser-277 is required for high affinity binding of agonists, but not antagonists. An N181S mutant lost affinity for adenosine agonists substituted at N6 or C-2, but not at C-5'. The mutant receptors I274A, S277A, and H278A showed full stimulation of adenylate cyclase at high concentrations of CGS 21680. The functional agonist potencies at mutant receptors that lacked radioligand binding were > 30-fold less than those at the wild type receptor. His-250 appears to be a required component of a hydrophobic pocket, and H-bonding to this residue is not essential. On the other hand, replacement of His-278 with other aromatic residues was not tolerated in ligand binding. Thus, some of the residues targeted in this study may be involved in the direct interaction with ligands in the human A2a adenosine receptor. A molecular model based on the structure of rhodopsin, in which the 5'-NH in NECA is hydrogen bonded to Ser-277 and His-278, was developed in order to visualize the environment of the ligand binding site.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7775460      PMCID: PMC3427751          DOI: 10.1074/jbc.270.23.13987

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Use of eukaryotic expression technology in the functional analysis of cloned genes.

Authors:  B R Cullen
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

2.  D2-dopamine receptor-mediated inhibition of cyclic AMP formation in striatal neurons in primary culture.

Authors:  S Weiss; M Sebben; J A Garcia-Sainz; J Bockaert
Journal:  Mol Pharmacol       Date:  1985-06       Impact factor: 4.436

3.  [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.

Authors:  M F Jarvis; R Schulz; A J Hutchison; U H Do; M A Sills; M Williams
Journal:  J Pharmacol Exp Ther       Date:  1989-12       Impact factor: 4.030

4.  Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor.

Authors:  C D Strader; M R Candelore; W S Hill; I S Sigal; R A Dixon
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

5.  A1 adenosine receptors. Two amino acids are responsible for species differences in ligand recognition.

Authors:  A L Tucker; A S Robeva; H E Taylor; D Holeton; M Bockner; K R Lynch; J Linden
Journal:  J Biol Chem       Date:  1994-11-11       Impact factor: 5.157

6.  Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia.

Authors:  S Ferré; W T O'Connor; P Snaprud; U Ungerstedt; K Fuxe
Journal:  Neuroscience       Date:  1994-12       Impact factor: 3.590

7.  Identification of the A2 adenosine receptor binding subunit by photoaffinity crosslinking.

Authors:  W W Barrington; K A Jacobson; A J Hutchison; M Williams; G L Stiles
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells.

Authors:  H Okayama; P Berg
Journal:  Mol Cell Biol       Date:  1983-02       Impact factor: 4.272

10.  Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.

Authors:  A Enjalbert; J Bockaert
Journal:  Mol Pharmacol       Date:  1983-05       Impact factor: 4.436

View more
  63 in total

Review 1.  Structural organization of G-protein-coupled receptors.

Authors:  A L Lomize; I D Pogozheva; H I Mosberg
Journal:  J Comput Aided Mol Des       Date:  1999-07       Impact factor: 3.686

2.  Identification by site-directed mutagenesis of residues involved in ligand recognition and activation of the human A3 adenosine receptor.

Authors:  Zhan-Guo Gao; Aishe Chen; Dov Barak; Soo-Kyung Kim; Christa E Müller; Kenneth A Jacobson
Journal:  J Biol Chem       Date:  2002-03-12       Impact factor: 5.157

3.  Constitutive activation of A(3) adenosine receptors by site-directed mutagenesis.

Authors:  A Chen; Z G Gao; D Barak; B T Liang; K A Jacobson
Journal:  Biochem Biophys Res Commun       Date:  2001-06-15       Impact factor: 3.575

4.  Molecular modeling of the human A2a adenosine receptor.

Authors:  A A Ivanov; I I Baskin; V A Palyulin; N S Zefirov
Journal:  Dokl Biochem Biophys       Date:  2003 Mar-Apr       Impact factor: 0.788

5.  Mutagenesis reveals structure-activity parallels between human A2A adenosine receptors and biogenic amine G protein-coupled receptors.

Authors:  Q Jiang; B X Lee; M Glashofer; A M van Rhee; K A Jacobson
Journal:  J Med Chem       Date:  1997-08-01       Impact factor: 7.446

Review 6.  Neoceptors: reengineering GPCRs to recognize tailored ligands.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao; Bruce T Liang
Journal:  Trends Pharmacol Sci       Date:  2007-02-05       Impact factor: 14.819

7.  Homology modelling of the human adenosine A2B receptor based on X-ray structures of bovine rhodopsin, the beta2-adrenergic receptor and the human adenosine A2A receptor.

Authors:  Farag F Sherbiny; Anke C Schiedel; Astrid Maass; Christa E Müller
Journal:  J Comput Aided Mol Des       Date:  2009-11       Impact factor: 3.686

8.  Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition.

Authors:  Q Jiang; A M Van Rhee; J Kim; S Yehle; J Wess; K A Jacobson
Journal:  Mol Pharmacol       Date:  1996-09       Impact factor: 4.436

9.  Ligand binding and subtype selectivity of the human A(2A) adenosine receptor: identification and characterization of essential amino acid residues.

Authors:  Veli-Pekka Jaakola; J Robert Lane; Judy Y Lin; Vsevolod Katritch; Adriaan P Ijzerman; Raymond C Stevens
Journal:  J Biol Chem       Date:  2010-02-10       Impact factor: 5.157

10.  Molecular Architecture of G Protein-Coupled Receptors.

Authors:  A Michiel van Rhee; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  1996-01-01       Impact factor: 4.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.